Table 3: Relative excess hazard ratios for mortality after diagnosis of hepatocellular carcinoma using the expected hazard from Ontario life tables, 1990–2009 (Model 1)*
ParameterRelative excess hazard ratio
(95% CI)
Intercept1.724 (1.451–2.047)
Year of diagnosis
1990–1994Reference
1995–19990.787 (0.706–0.877)
2000–20040.730 (0.659–0.810)
2005–20090.773 (0.698–0.855)
Follow-up after diagnosis, yr
1Reference
20.594 (0.546–0.646)
30.512 (0.455–0.576)
40.541 (0.468–0.625)
50.348 (0.278–0.437)
Age at diagnosis, yr
< 60Reference
60–690.960 (0.886, 1.041)
70–790.909 (0.837, 0.986)
≥ 801.020 (0.903, 1.152)
Sex
FemaleReference
Male1.031 (0.956–1.111)
Charlson–Deyo comorbidity index
   0Reference
   10.791 (0.726–0.863)
   20.551 (0.496–0.612)
≥ 30.500 (0.446–0.562)
No hospitalization record0.523 (0.480–0.568)
HCC treatment
Curative (yes v. no)0.229 (0.204–0.257)
Noncurative (yes v. no)0.664 (0.603–0.731)
Palliative care (yes v. no)1.393 (1.238–1.566)
No treatment (yes v. no)1.459 (1.276–1.670)

Note: CI = confidence interval, model deviance = 3901.73, degrees of freedom (df) = 2851.
*Generalized linear model using Poisson error structure.